The Food and Drug Administration (FDA) has approved Khindivi ™ (hydrocortisone) oral solution as a replacement therapy in pediatric patients aged 5 years and older with adrenocortical insufficiency.

Eton Pharmaceuticals (ETON) stock gains as the FDA approved Khindivi its oral hydrocortisone solution for children with adrenocortical insufficiency. Read more here.

Eton Pharmaceuticals’ new drug application (NDA) for Khindivi, an oral solution of hydrocortisone, has received US Food and ...

Acting on confidential information, the STF team from Siliguri intercepted a consignment of Yaba tablets, valued at approximately Rs 20 lakh, which had been ingeniously concealed inside a traditional ...